Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growthJaya Sangodkar, Goutham Narla, Abbey Perl et al.|Journal of Clinical Investigation|2017Cited by 200
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancerBérengère Salomé, Nina Bhardwaj, Geoffrey Kelly et al.|Cancer Cell|2022Cited by 127
Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate CancerKimberly McClinch, Matthew D. Galsky, Rita A. Avelar et al.|Cancer Research|2018Cited by 86
Abstract A38: Therapeutic targeting of oncogenic KRAS signaling using a novel small molecule agonist of the PP2A tumor suppressor geneJaya Sangodkar, Goutham Narla, Sahar Mazhar et al.|Molecular Cancer Research|2014Cited by 0
Abstract 3865: Therapeutic activation of protein phosphatase 2A for the treatment of lung cancerJaya Sangodkar, Goutham Narla, Rita Tohmé et al.|Cancer Research|2016Cited by 0